seed
Stage
2017
Founded
1
Investors
About
Avelo Therapeutics is a biotech company developing novel small molecule therapeutics for cancer treatment. Their lead program targets a novel mechanism in the DNA damage response pathway to overcome resistance to current therapies.
Explore Avelo Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.